keyword
Keywords Randomized control trial AND p...

Randomized control trial AND pulmonary

https://read.qxmd.com/read/38652265/umeclidinium-plus-vilanterol-versus-fluticasone-propionate-plus-salmeterol-for-chronic-obstructive-pulmonary-disease-a-meta-analysis-of-randomized-controlled-trials
#1
JOURNAL ARTICLE
Chunjuan Zhai, Fen Wang, Ruie Xu, Xia Sun, Wenbin Ma, Li Wang
PURPOSE: Umeclidinium plus vilanterol (UMEC/VI) is an inhaled long-acting muscarinic antagonist/long-acting beta2-agonist (LAMA/LABA), recently approved as once-daily maintenance therapy for chronic obstructive pulmonary disease (COPD). This meta-analysis aims to assess the efficacy and safety of UMEC/VI compared with fluticasone propionate plus salmeterol (FP/SAL). METHODS: A systematic search was conducted by a trained medical research librarian across MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Chinese Biomedical Literature Database (CBM) for randomized controlled trials comparing UMEC/VI with FP/SAL in COPD patients...
April 23, 2024: Postgraduate Medical Journal
https://read.qxmd.com/read/38651067/association-between-statin-use-and-acute-pulmonary-embolism-in-intensive-care-unit-patients-with-sepsis-a-retrospective-cohort-study
#2
JOURNAL ARTICLE
Dengcang Yang, Yanyan He, Qianqian Wang, Yi Yu
INTRODUCTION: Acute pulmonary embolism (APE) is a life-threatening medical condition that is frequently encountered and associated with significant incidence and mortality rates, posing a substantial threat to patients' well-being and quality of life. Sepsis is prominent independent risk factor for the development of APE. Despite recent investigations indicating a reduced APE risk through statin therapy, its impact on patients with sepsis and APE remains unresolved. METHODS: The Medical Information Mart for Intensive Care (MIMIC)-IV database was utilized to identify patients diagnosed with sepsis and APE, irrespective of statin treatment status, as part of this study...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38649992/impact-of-perioperative-low-molecular-weight-heparin-therapy-on-clinical-events-of-elderly-patients-with-prior-coronary-stents-implanted-12-months-undergoing-non-cardiac-surgery-a-randomized-placebo-controlled-trial
#3
JOURNAL ARTICLE
Bin Wang, Yanhui Su, Cong Ma, Lining Xu, Qunxia Mao, Wenjia Cheng, Qingming Lu, Ying Zhang, Rong Wang, Yan Lu, Jing He, Shihao Chen, Lei Chen, Tianzhi Li, Linggen Gao
BACKGROUND: Little is known about the safety and efficacy of discontinuing antiplatelet therapy via LMWH bridging therapy in elderly patients with coronary stents implanted for > 12 months undergoing non-cardiac surgery. This randomized trial was designed to compare the clinical benefits and risks of antiplatelet drug discontinuation via LMWH bridging therapy. METHODS: Patients were randomized 1:1 to receive subcutaneous injections of either dalteparin sodium or placebo...
April 23, 2024: BMC Medicine
https://read.qxmd.com/read/38647070/venous-vascular-closure-system-versus-figure-of-eight-suture-following-atrial-fibrillation-ablation-the-style-af-study
#4
JOURNAL ARTICLE
R Tilz, M Feher, J Vogler, K Bode, A Duta, A Ortolan, Lisbeth Delgado Lopez, M Küchler, R Mamaev, E Lyan, Philipp Sommer, M Braun, V Sciacca, T Demming, V Maslova, K H Kuck, C-H Heeger, C Eitel, S S Popescu
BACKGROUND: Simplified ablation technologies for pulmonary vein isolation (PVI) are increasingly performed worldwide. One of the most common complications following PVI are vascular access-related complications. Lately, venous closure systems (VCS) were introduced into clinical practice, aiming to reduce the time of bedrest, to increase the patients' comfort and to reduce vascular access-related complications. AIMS: To compare the safety and efficacy of using a VCS to achieve haemostasis following single shot PVI to the actual standard of care (figure-of-eight suture and manual compression (MC))...
April 22, 2024: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/38646153/inhaled-no-at-a-crossroads-in-cardiac-surgery-current-need-to-improve-mechanistic-understanding-clinical-trial-design-and-scientific-evidence
#5
REVIEW
Stefan Muenster, Iratxe Zarragoikoetxea, Andrea Moscatelli, Joan Balcells, Philippe Gaudard, Philippe Pouard, Nandor Marczin, Stefan P Janssens
Inhaled nitric oxide (NO) has been used in pediatric and adult perioperative cardiac intensive care for over three decades. NO is a cellular signaling molecule that induces smooth muscle relaxation in the mammalian vasculature. Inhaled NO has the unique ability to exert its vasodilatory effects in the pulmonary vasculature without any hypotensive side-effects in the systemic circulation. In patients undergoing cardiac surgery, NO has been reported in numerous studies to exert beneficial effects on acutely lowering pulmonary artery pressure and reversing right ventricular dysfunction and/or failure...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38643115/saliva%C3%A2-microbiome%C3%A2-derived-signatures-expected-to-become-a-potential-biomarker-for-pulmonary-nodules-mcepn-1
#6
JOURNAL ARTICLE
Yifeng Ren, Qiong Ma, Xiao Zeng, Chunxia Huang, Shiyan Tan, Xi Fu, Chuan Zheng, Fengming You, Xueke Li
BACKGROUND: Oral microbiota imbalance is associated with the progression of various lung diseases, including lung cancer. Pulmonary nodules (PNs) are often considered a critical stage for the early detection of lung cancer; however, the relationship between oral microbiota and PNs remains unknown. METHODS: We conducted a 'Microbiome with pulmonary nodule series study 1' (MCEPN-1) where we compared PN patients and healthy controls (HCs), aiming to identify differences in oral microbiota characteristics and discover potential microbiota biomarkers for non-invasive, radiation-free PNs diagnosis and warning in the future...
April 20, 2024: BMC Microbiology
https://read.qxmd.com/read/38640604/minor-hepatectomy-combined-with-cholangioplasty-and-cholangiojejunostomy-for-bismuth-ii-hilar-cholangiocarcinoma-a-propensity-score-matching-analysis
#7
JOURNAL ARTICLE
Jun Yang, Zixuan Fu, Weiwei Sheng, Zhihao Huang, Jiandong Peng, Pengcheng Zhou, Jianghui Xiong, Rongshou Wu, Wenjun Liao, Linquan Wu, Enliang Li
BACKGROUND: The optimal surgical approach for Bismuth II hilar cholangiocarcinoma (HCCA) remains controversial. This study compared perioperative and oncological outcomes between minor and major hepatectomy. MATERIALS AND METHODS: One hundred and seventeen patients with Bismuth II HCCA who underwent hepatectomy and cholangiojejunostomy between January 2018 and December 2022 were retrospectively investigated. Propensity score matching created a cohort of 62 patients who underwent minor (n = 31) or major (n = 31) hepatectomy...
April 12, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38637891/treatment-of-covid-19-associated-ards-with-umbilical-cord-derived-mesenchymal-stromal-cells-in-the-stroma-cov-2-multicenter-randomized-double-blind-trial-long-term-safety-respiratory-function-and-quality-of-life
#8
JOURNAL ARTICLE
Alexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, Jean-Luc Diehl, Alexandre Demoule, Djillali Annane, Clémence Marois, Sophie Demeret, Emmanuel Weiss, Guillaume Voiriot, Muriel Fartoukh, Jean-Michel Constantin, Bruno Mégarbane, Gaëtan Plantefève, Hélène Boucher-Pillet, Guillaume Churlaud, Audrey Cras, Camille Maheux, Chloé Pezzana, Mamadou Hassimiou Diallo, Said Lebbah, Jacques Ropers, Joe-Elie Salem, Christian Straus, Philippe Menasché, Jérôme Larghero, Antoine Monsel
BACKGROUND: The STROMA-CoV-2 study was a French phase 2b, multicenter, double-blind, randomized, placebo-controlled clinical trial that did not identify a significant efficacy of umbilical cord-derived mesenchymal stromal cells in patients with SARS-CoV-2-induced acute respiratory distress syndrome. Safety on day 28 was found to be good. The aim of our extended study was to assess the 6- and 12-month safety of UC-MSCs administration in the STROMA-CoV-2 cohort. METHODS: A detailed multi-domain assessment was conducted at 6 and 12 months following hospital discharge focusing on adverse events, lung computed tomography-scan, pulmonary and muscular functional status, and quality of life in the STROMA-CoV-2 cohort including SARS-CoV-2-related early (< 96 h) mild-to-severe acute respiratory distress syndrome...
April 19, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38636796/rationale-and-study-design-for-an-individualized-perioperative-open-lung-ventilatory-approach-in-emergency-abdominal-laparotomy-scopy-study-protocol-for-a-prospective-international-randomized-controlled-trial
#9
JOURNAL ARTICLE
G Laguna, F Suárez-Sipmann, G Tusman, J Ripollés, O Díaz-Cambronero, R Pujol, E Rivas, I Garutti, R Mellado, J Vallverdú, A Jacas, A Fervienza, R Marrero, J Librero, J Villar, C Ferrando
BACKGROUND: Postoperative pulmonary complications (PPC) are the most frequent postoperative complications, with an estimated prevalence in elective surgery ranging from 20% in observational cohort studies to 40% in randomized clinical trials. However, the prevalence of PPCs in patients undergoing emergency abdominal surgery is not well defined. Lung-protective ventilation aims to minimize ventilator-induced lung injury and reduce PPCs. The open lung approach (OLA), which combines recruitment manoeuvres (RM) and positive end-expiratory pressure (PEEP) titration, aims to minimize areas of atelectasis and the development of PPCs; however, there is no conclusive evidence in the literature that OLA can prevent PPCs...
April 16, 2024: Revista española de anestesiología y reanimación
https://read.qxmd.com/read/38636135/the-efficacy-of-pulmonary-artery-catheters-in-reducing-mortality-in-acute-heart-failure-cardiogenic-shock-a-systematic-review
#10
REVIEW
Brianna Wagaman
BACKGROUND: Cardiogenic shock (CS), a complex and life-threatening medical condition, has an astounding hospital mortality rate spanning from 40 % to 59 %. Frequently, CS requires the use of pulmonary artery catheters (PACs) for management. OBJECTIVE: This literature review aims to investigate the relationship between PAC utilization in CS patients and in-hospital 30-day mortality rates compared to noninvasive vital sign monitoring alone. METHODS: An integrative literature search was conducted from January 1, 2003, until August 1, 2023...
April 17, 2024: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/38634108/experience-with-four-month-rifapentine-and-moxifloxacin-based-tuberculosis-treatment-in-san-francisco
#11
JOURNAL ARTICLE
Janice K Louie, Rocio Agraz-Lara, Gustavo E Velásquez, Allison Phillips, John D Szumowski
BACKGROUND: A multicountry randomized controlled trial has demonstrated that pan-susceptible pulmonary tuberculosis (TB) can be successfully treated with a 4-month regimen of daily isoniazid, rifapentine, moxifloxacin, and pyrazinamide (HPMZ). We piloted HPMZ in San Francisco (SF) using a modified version of the US Centers for Disease Control and Prevention HPMZ treatment guidelines. METHODS: In this retrospective cohort, patients consecutively referred to SF TB clinic were evaluated for HPMZ eligibility based on preestablished inclusion/exclusion criteria...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38633618/wuhu-decoction-combined-with-azithromycin-for-treatment-of-mycoplasma-pneumoniae-pneumonia-in-asian-children-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#12
Shuo Yang, Xinying Liu, Huizhe Wang, Haokai Wang, Dan Sun, Yaowei Han, Huanmin Li, Xinmin Li
Objective: This study constitutes a pioneering systematic review and meta analysis delving into the clinical efficacy and safety of the combined therapy involving Wuhu Decoction and azithromycin for treating Mycoplasma pneumoniae pneumonia in pediatric patients. Methods: This study conducted a comprehensive computerized search, covering 6 Chinese databases and 6 English databases, to collect randomized controlled trials related to the combined use of Wuhu Decoction and azithromycin for treating Mycoplasma pneumoniae pneumonia in pediatric patients...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38630494/atrial-shunt-device-effects-on-cardiac-structure-and-function-in-heart-failure-with-preserved-ejection-fraction-the-reduce-lap-hf-ii-randomized-clinical-trial
#13
JOURNAL ARTICLE
Ravi B Patel, Frank E Silvestry, Jan Komtebedde, Scott D Solomon, Gerd Hasenfuß, Sheldon E Litwin, Barry A Borlaug, Matthew J Price, Rami Kawash, Scott L Hummel, Donald E Cutlip, Martin B Leon, Dirk J van Veldhuisen, Andreas J Rieth, Scott McKenzie, Heiko Bugger, Jeremy A Mazurek, Samir R Kapadia, Marc Vanderheyden, Bonnie Ky, Sanjiv J Shah
IMPORTANCE: Although the results of A Study to Evaluate the Corvia Medical Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF II) trial were neutral overall, atrial shunt therapy demonstrated potential efficacy in responders (no latent pulmonary vascular disease and no cardiac rhythm management device). Post hoc analyses were conducted to evaluate the effect of shunt vs sham stratified by responder status. OBJECTIVE: To evaluate the effect of atrial shunt vs sham control on cardiac structure/function in the overall study and stratified by responder status...
April 17, 2024: JAMA Cardiology
https://read.qxmd.com/read/38629953/is-incentive-spirometry-superior-to-standard-care-in-postoperative-cardiac-surgery-on-clinical-outcomes-and-length-of-hospital-and-intensive-care-unit-stay-a-systematic-review-with-meta-analysis
#14
REVIEW
Hiago Vinicius Costa Silva, Adriana Claudia Lunardi, Ana Carolina Pereira Nunes Pinto, Juliana Ribeiro Fonseca Franco de Macedo, Elinaldo da Conceição Dos Santos
INTRODUCTION: Cardiac surgery is a frequent surgical procedure and may present a high risk of complications. Among the prophylactic strategies studied to decrease the rates of negative outcomes, respiratory care seems to reduce pulmonary complications. Incentive spirometry (IS) is a low-cost, respiratory exercise technique, used for the prevention and treatment of postoperative pulmonary complications (PPC). The aim of this review was to evaluate whether IS is superior to respiratory care, mobilization exercises, and noninvasive ventilation on PPC, and clinical outcomes...
April 17, 2024: Brazilian Journal of Cardiovascular Surgery
https://read.qxmd.com/read/38622671/the-effect-of-goal-directed-crystalloid-versus-colloid-administration-on-postoperative-spirometry-parameters-a-substudy-of-a-randomized-controlled-clinical-trial
#15
JOURNAL ARTICLE
Mina Obradovic, Florian Luf, Christian Reiterer, Sebastian Schoppmann, Andrea Kurz, Edith Fleischmann, Barbara Kabon
BACKGROUND: Pulmonary function is impaired after major abdominal surgery and might be less impaired by restrictive fluid administration. Under the assumption of a fluid-sparing effect of colloids, we tested the hypothesis that an intraoperative colloid-based goal-directed fluid management strategy impairs postoperative pulmonary function parameters less compared to goal-directed crystalloid administration. METHODS: We performed a preplanned, single-center substudy within a recently published trial evaluating the effect of goal-directed crystalloids versus colloids on a composite of major complications...
April 15, 2024: Perioperative Medicine
https://read.qxmd.com/read/38621405/safety-of-a-controlled-human-infection-model-of-tuberculosis-with-aerosolised-live-attenuated-mycobacterium-bovis-bcg-versus-intradermal-bcg-in-bcg-naive-adults-in-the-uk-a-dose-escalation-randomised-controlled-phase-1-trial
#16
JOURNAL ARTICLE
Iman Satti, Julia L Marshall, Stephanie A Harris, Rachel Wittenberg, Rachel Tanner, Raquel Lopez Ramon, Morven Wilkie, Fernando Ramos Lopez, Michael Riste, Daniel Wright, Marco Polo Peralta Alvarez, Nicola Williams, Hazel Morrison, Elena Stylianou, Pedro Folegatti, Daniel Jenkin, Samantha Vermaak, Linnea Rask, Ingrid Cabrera Puig, Rebecca Powell Doherty, Alison Lawrie, Paul Moss, Timothy Hinks, Henry Bettinson, Helen McShane
BACKGROUND: Mycobacterium tuberculosis is the main causative agent of tuberculosis. BCG, the only licensed vaccine, provides inadequate protection against pulmonary tuberculosis. Controlled human infection models are useful tools for vaccine development. We aimed to determine a safe dose of aerosol-inhaled live-attenuated Mycobacterium bovis BCG as a surrogate for M tuberculosis infection, then compare the safety and tolerability of infection models established using aerosol-inhaled and intradermally administered BCG...
April 12, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38618447/effectiveness-of-telemedicine-interventions-in-chronic-obstructive-pulmonary-disease-copd-management-a-randomized-controlled-trial-comparing-yoga-therapy-and-pulmonary-rehabilitation-over-three-months
#17
JOURNAL ARTICLE
Ruchi Dua, Saloni Malik, Ajeet S Bhadoria, Osama Neyaz, Ajay S Krishnan, Chinmay Pandya
Background Pulmonary rehabilitation (PR) is an integral part of non-pharmacological therapy in chronic obstructive pulmonary disease (COPD). Yoga therapy (YT) has been shown to be beneficial in COPD, but the lack of large well-designed trials and standardized modules restricts its acceptability. This randomized control trial compares these two modalities in COPD patients via supervised tele-intervention. Objectives The primary objective of the study is to compare a 45-minute, five-days-per-week series of tele-YT (T-YT) with tele-PR (T-PR) for three months in terms of exercise capacity (6-Minute Walk Distance (6MWD)) in COPD patients...
March 2024: Curēus
https://read.qxmd.com/read/38614852/hypofractionation-for-regional-nodal-irradiation-in-breast-cancer-best-of-both-the-worlds
#18
REVIEW
Budhi Singh Yadav, Treshita Dey
Locoregional radiotherapy play an important role in controlling the disease after surgery in patients with breast cancer. Radiotherapy schedules vary from conventional fraction to hypofractionation. The purpose of this review is to get an insight into the data on regional nodal irradiation (RNI) with hypofractionation in patients with breast cancer. This systematic review was constructed in accordance with Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) framework. Electronic databases such as PubMed, Cochrane and EMBASE were searched from January 1, 2023 to March 31, 2023 to identify studies published in English language on hypofractionated RNI in post mastectomy patients...
March 14, 2024: Clinical Breast Cancer
https://read.qxmd.com/read/38613061/improvement-of-lung-function-by-micronutrient-supplementation-in-patients-with-copd-a-systematic-review-and-meta-analysis
#19
REVIEW
Mingxin Li, Liangjie Zhao, Chenchen Hu, Yue Li, Yang Yang, Xiaoqi Zhang, Quanguo Li, Aiguo Ma, Jing Cai
BACKGROUND: A healthy, well-balanced diet plays an essential role in respiratory diseases. Since micronutrient deficiency is relatively common in patients with chronic obstructive pulmonary disease (COPD), micronutrient supplementation might have the beneficial health effects in those patients. This systematic review and meta-analysis aimed to demonstrate the impact of micronutrient supplementation on the lung function of patients with COPD. METHODS: The PubMed, Cochrane Library, and Web of Science databases were searched from their corresponding creation until February 2024...
April 1, 2024: Nutrients
https://read.qxmd.com/read/38613004/impact-of-1-year-supplementation-with-high-rich-docosahexaenoic-acid-dha-on-clinical-variables-and-inflammatory-biomarkers-in-pediatric-cystic-fibrosis-a-randomized-double-blind-controlled-trial
#20
JOURNAL ARTICLE
Roser Ayats-Vidal, Montserrat Bosque-García, Begoña Cordobilla, Oscar Asensio-De la Cruz, Miguel García-González, Susana Loureda-Pérez, Elena Fernández-López, Eva Robert-Barriocanal, Andrea Valiente-Planas, Joan Carles Domingo
A randomized, double-blind, and placebo-controlled study was conducted to assess the effect of dietary supplementation with high-rich docosahexaenoic acid (DHA) (Tridocosahexanoin-AOX® 70%) at 50 mg/kg/day in pediatric patients with cystic fibrosis (CF) as compared with placebo. The duration of supplementation was 12 months. A total of 22 patients were included, with 11 in the DHA group and 11 in the placebo group. The mean age was 11.7 years. The outcome variables were pulmonary function, exacerbations, sputum cellularity, inflammatory biomarkers in sputum and peripheral blood, and anthropometric variables...
March 27, 2024: Nutrients
keyword
keyword
85257
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.